Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils

被引:120
作者
Khreiss, T
Józef, L
Potempa, LA
Filep, NG
机构
[1] Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ H1T 2M4, Canada
[2] Univ Montreal, Montreal, PQ, Canada
[3] Immtech Int Inc, Vernon Hills, IL USA
关键词
C-reactive protein; leukocytes; interleukins; signal transduction; inflammation;
D O I
10.1161/01.RES.0000183881.11739.CB
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma levels of C-reactive protein (CRP), nitrotyrosine, and interleukin-8 (IL-8) are known predictors of acute cardiovascular events. Peroxynitrite (ONOO-) may function as an intracellular signal for the production of IL-8; however, it is not known whether CRP regulates these events. Emerging evidence suggests that some bioactivities of CRP are expressed only when the pentameric structure of CRP is lost, resulting in formation of monomeric or modified CRP (mCRP). We studied the impact of human native CRP and bioengineered mCRP that cannot rearrange into the pentameric structure on ONOO- formation and ONOO--mediated IL-8 gene expression in human leukocytes. Incubation of human whole blood or isolated neutrophils with mCRP (0.1 to 100 mu g/mL) for 4 hours increased IL-8 gene expression and secretion that was blocked approximate to 70% by the NO synthase inhibitor N omega-nitro-L-arginine methyl ester (L-NAME). In neutrophils, mCRP simultaneously increased superoxide production and endothelial nitric oxide synthase-mediated NO formation, leading to enhanced ONOO- formation, and consequently activation of nuclear factor-kappa B and activator protein-1. Native CRP had no detectable effect at 4 hours, whereas it enhanced IL-8 release after a 24-hour incubation that was blocked by L-NAME. An anti-CD16 antibody, but not an anti-CD32 antibody, produced 60% to 70% reductions in mCRP-stimulated NO formation and IL-8 release (both P < 0.05). These results suggest that loss of the pentameric symmetry in CRP, resulting in formation of mCRP, leads to IL-8 release from human neutrophils via peroxynitrite-mediated activation of nuclear factor-kappa B and activator protein-1.
引用
收藏
页码:690 / 697
页数:8
相关论文
共 47 条
[31]   EXPRESSION, DETECTION AND ASSAY OF A NEOANTIGEN (NEO-CRP) ASSOCIATED WITH A FREE, HUMAN C-REACTIVE PROTEIN SUBUNIT [J].
POTEMPA, LA ;
SIEGEL, JN ;
FIEDEL, BA ;
POTEMPA, RT ;
GEWURZ, H .
MOLECULAR IMMUNOLOGY, 1987, 24 (05) :531-541
[32]   EXPRESSION OF A C-REACTIVE PROTEIN NEOANTIGEN (NEO-CRP) IN INFLAMED RABBIT LIVER AND MUSCLE [J].
REES, RF ;
GEWURZ, H ;
SIEGEL, JN ;
COON, J ;
POTEMPA, LA .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 48 (01) :95-107
[33]   Signal transduction by immunoglobulin Fc receptors [J].
Sánchez-Mejorada, G ;
Rosales, C .
JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 63 (05) :521-533
[34]   FORMATION AND RELEASE OF NITRIC-OXIDE FROM HUMAN-NEUTROPHILS AND HL-60 CELLS INDUCED BY A CHEMOTACTIC PEPTIDE, PLATELET ACTIVATING FACTOR AND LEUKOTRIENE-B4 [J].
SCHMIDT, HHHW ;
SEIFERT, R ;
BOHME, E .
FEBS LETTERS, 1989, 244 (02) :357-360
[35]   DITHIOCARBAMATES AS POTENT INHIBITORS OF NUCLEAR FACTOR KAPPA-B ACTIVATION IN INTACT-CELLS [J].
SCHRECK, R ;
MEIER, B ;
MANNEL, DN ;
DROGE, W ;
BAEUERLE, PA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (05) :1181-1194
[36]   Tubular staining of modified C-reactive protein in diabetic chronic kidney disease [J].
Schwedler, SB ;
Guderian, F ;
Dämmrich, J ;
Potempa, LA ;
Wanner, C .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (11) :2300-2307
[37]   Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy [J].
Shishehbor, MH ;
Aviles, RJ ;
Brennan, ML ;
Fu, XM ;
Goormastic, M ;
Pearce, GL ;
Gokce, N ;
Keaney, JF ;
Penn, MS ;
Sprecher, DL ;
Vita, JA ;
Hazen, SL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (13) :1675-1680
[38]   C-reactive protein binding to FcγRIIa on human monocytes and neutrophils is allele-specific [J].
Stein, MP ;
Edberg, JC ;
Kimberly, RP ;
Mangan, EK ;
Bharadwaj, D ;
Mold, C ;
Du Clos, TW .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (03) :369-376
[39]  
SUZUKI YJ, 1994, J IMMUNOL, V153, P5008
[40]   The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury [J].
Szabo, C .
SHOCK, 1996, 6 (02) :79-88